Journal of Hepatology and Gastrointestinal disorders
Open Access
ISSN: 2475-3181
+44-20-4587-4809
ISSN: 2475-3181
+44-20-4587-4809
Department of General and Laparoscopic Surgery, Central University, Ecuador
Research
Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemo- therapy (HIPEC), Report of the First Series of Cases in Ecuador
Author(s): Gordillo Villamar Rene*, Medina Donoso Gabriel, Angos Mediavilla Veronica and Gordillo Aldas Daniela
Cyto-Reductive Surgery (CRS) + intraperitoneal hyperthermic chemotherapy (HIPEC) has a survival rate at 10 and 15 years
of 63% and 59% respectively in patients with peritoneal neoplasms; severe morbidity is described in older adult patients from
17 to 56% in experienced centers, with a hospital mortality of up to 8%, there is some resistance to its implementation due to
complications related to 56%, but the expectation of potential benefit is always attractive... View More»